Description
GLIFEMPA-LIN XR TABS 30`S is a Prescription Only Medicine (POM), commonly supplied in a pack of 30 extended-release tablets. This medication contains a triple combination of Empagliflozin (SGLT2 inhibitor), Linagliptin (DPP-4 inhibitor), and Metformin Hydrochloride Extended Release (XR) (Biguanide), with common strengths like (10mg Empagliflozin / 5mg Linagliptin / 1000mg Metformin XR). Manufactured by Galaxy Pharmaceutical Limited (in Kenya), it is used to manage Type 2 Diabetes Mellitus when other treatments are insufficient. This comprehensive therapy effectively lowers blood sugar and provides significant benefits in reducing the risk of cardiovascular events and progression of kidney disease in diabetic patients.
